Vineeta Agarwala, M.D., Ph.D.

Vineeta Agarwala, M.D., Ph.D., serves as a member of Braveheart Bio’s board of directors. Dr. Agarwala has served as a General Partner at Andreessen Horowitz since January 2020, where she focuses on investments in biotechnology and health technology companies and serves on the boards of directors of several private portfolio companies. Prior to joining Andreessen Horowitz, Dr. Agarwala served as a Venture Partner at Google Ventures, where she supported early-stage investments across biotechnology and digital health. Dr. Agarwala is an Adjunct Clinical Assistant Professor at Stanford University School of Medicine, where she has practiced in the Division of Primary Care and Population Health since 2020. Dr. Agarwala holds a B.S. in Biophysics from Stanford University, an M.D. from Harvard Medical School through the Harvard-MIT HST Program, and a Ph.D. in Biophysics from Harvard University. She completed her residency in internal medicine at Stanford Hospital & Clinics.